Alpha 2.0
Login Register
» Articles » PMID: 3754266

Tentative Disk Diffusion Susceptibility Interpretive Criteria for BMY-28142, a New Cephalosporin

Overview
Journal J Clin Microbiol
Specialty Microbiology
Date 1986 Mar 1
PMID 3754266
Citations 5
Authors
P C Fuchs
R N Jones
A L Barry
C Thornsberry
Affiliations
Soon will be listed here.
Abstract

A total of 750 bacterial isolates, including 37 different species, were tested for susceptibility to BMY-28142 by standardized broth microdilution and disk diffusion tests. The zone diameter interpretive criteria tentatively suggested for the 30-micrograms BMY-28142 disk are as follows: susceptible = greater than or equal to 18 mm (MIC less than or equal to 8.0 micrograms/ml), resistant = less than or equal to 14 mm (MIC greater than or equal to 32 micrograms/ml), and indeterminate = 15 to 17 mm.

Citing Articles

Open randomized study of cefepime versus piperacillin-gentamicin for treatment of febrile neutropenic cancer patients.

Yamamura D, Gucalp R, CARLISLE P, Cimino M, Roberts J, Rotstein C Antimicrob Agents Chemother. 1997; 41(8):1704-8.

PMID: 9257745 PMC: 163989. DOI: 10.1128/AAC.41.8.1704.

Cefepime clinical pharmacokinetics.

Okamoto M, Nakahiro R, Chin A, Bedikian A Clin Pharmacokinet. 1993; 25(2):88-102.

PMID: 8403741 DOI: 10.2165/00003088-199325020-00002.

Development of test panel of beta-lactamases expressed in a common Escherichia coli host background for evaluation of new beta-lactam antibiotics.

Bradford P, Sanders C Antimicrob Agents Chemother. 1995; 39(2):308-13.

PMID: 7726487 PMC: 162532. DOI: 10.1128/AAC.39.2.308.

Interpretive criteria for the agar diffusion susceptibility test with ofloxacin.

Grimm H Drugs. 1987; 34 Suppl 1:14-9.

PMID: 3481315 DOI: 10.2165/00003495-198700341-00004.

Preliminary interpretive criteria for the Haemophilus Test Medium method using 30 micrograms cefepime disks.

Jones R Eur J Clin Microbiol Infect Dis. 1992; 11(2):207-8.

PMID: 1396744 DOI: 10.1007/BF01967086.

References
1.
Baker C, Thornsberry C, Jones R . In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains. Antimicrob Agents Chemother. 1980; 17(4):757-61. PMC: 283867. DOI: 10.1128/AAC.17.4.757. View
2.
Jones R, Thornsberry C, Barry A . In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporin. Antimicrob Agents Chemother. 1984; 25(6):710-8. PMC: 185628. DOI: 10.1128/AAC.25.6.710. View
3.
Fuchs P, Jones R, Barry A, Thornsberry C . Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin. Antimicrob Agents Chemother. 1985; 27(5):679-82. PMC: 180130. DOI: 10.1128/AAC.27.5.679. View
4.
Khan N, Bihl J, Schell R, LeFrock J, Weber S . Antimicrobial activities of BMY-28142, cefbuperazone, and cefpiramide compared with those of other cephalosporins. Antimicrob Agents Chemother. 1984; 26(4):585-90. PMC: 179970. DOI: 10.1128/AAC.26.4.585. View
5.
Tsuji A, Maniatis A, Bertram M, Young L . In vitro activity of BMY-28142 in comparison with those of other beta-lactam antimicrobial agents. Antimicrob Agents Chemother. 1985; 27(4):515-9. PMC: 180087. DOI: 10.1128/AAC.27.4.515. View